Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation

doi:10.3748/wjg.v22.i25.5790

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7438)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

720

WORD

312

HTML

3761

Figures (1-3)

247

Tables (1-5)

206

Sum=5246

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1042

Download

1150

Sum=2192

Jul 7, 2016 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 7, 2016; 22(25): 5790-5799
Published online Jul 7, 2016. doi: 10.3748/wjg.v22.i25.5790

Open in New Tab Full Size Figure Download Figure

Figure 1 Time interval between living donor liver transplantation and hepatocellular carcinoma recurrence. A: Whole study population; B: Comparison according to the Milan criteria at transplantation. HCC: Hepatocellular carcinoma; LDLT: Living donor liver transplantation.

Open in New Tab Full Size Figure Download Figure

Figure 2 Survival rates after hepatocellular carcinoma recurrence. A: Whole study population; B: Comparison between curative intent group and palliative intent group; C: Comparison according to the Milan criteria at living donor liver transplantation. HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 3 Survival rates after hepatocellular carcinoma recurrence in palliative treatment group (A) and curative treatment group (B). HCC: Hepatocellular carcinoma.

Citation: Na GH, Hong TH, You YK, Kim DG. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation. World J Gastroenterol 2016; 22(25): 5790-5799
URL: https://www.wjgnet.com/1007-9327/full/v22/i25/5790.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i25.5790